At the request of Rep. Waxman and Senators Tom Harkin, Barbara Mikulski, and Olympia Snowe, GAO reviewed drug products withdrawn from the U.S. market since January 1, 1997. This review revealed that eight of ten prescription drugs withdrawn posed greater risk for women than for men.